Credit Suisse »

Tscan Therapeutics shares owned by Credit Suisse

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Credit Suisse from 13F filings

Historical chart of Credit Suisse investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Credit Suisse

Quarter filed Position value Share count Share price at filing
2024-03-31 $138k 17k 7.94